Greatland and Singerman sign 35,662 s/f lease to Keros Therapeutics at Revolution Labs in Lexington, MA

Lexington, MA Greatland Realty Partners, a Boston-based real estate development firm, along with joint-venture partner Singerman Real Estate (SRE), signed a long-term lease agreement with Keros Therapeutics, Inc. at Revolution Labs. The terms of the deal include an eight-year lease agreement for 35,662 s/f within the new, 180,000 s/f development in one of the nation’s leading life sciences, pharmaceutical, and biotech super clusters.

Greatland and Singerman were represented by JLL in the transaction, with Keros represented by CBRE. The lease is the first deal signed at the property, which will be ready for occupancy in Q4 of 2022. Callahan Construction Managers is the general contractor for the project.

“We are thrilled to welcome Keros as our first customer at Revolution Labs in Lexington,” said Teri Ford, director of development at Greatland. “Revolution Labs will deliver an unmatched work experience and provide Keros with brand new, state-of-the-art lab space to support its continued scientific research and development activities.”

Designed by architecture firm SGA, Revolution Labs is optimally situated at 1050 Waltham St., south of Rte. 2 in a walkable, mixed-use neighborhood with access to I-95. Less than 15 minutes from Boston/Cambridge, Revolution Labs offers 180,000 s/f of lab ready infrastructure, along with LEED Gold, WELL Building and WiredScore Gold certifications, and numerous onsite amenities such as covered parking, fitness, dining, and ample meeting and outdoor space.